|
|
429 Rockaway Valley Rd
Unit 1200
Boonton
NJ
07005
United States
973-402-6101
|
|
Private
|
EUROIMMUN was founded in September 1987 and today has its headquarters in Lübeck, Germany. Branches are situated in Groß Grönau near Lübeck, in Rennersdorf (Upper Lusatia, Saxony) and in Pegnitz (Upper Franconia, Bavaria). Further EUROIMMUN subsidiaries can be found in Canada (Mississauga), China (Beijing, Hangzhou), Great Britain (Pontypool in Wales), Italy (Padua), Lebanon (Beirut), Poland (Wroclaw), Switzerland (Lucerne), Singapore, South Africa (Capetown), Turkey (Istanbul), the USA (New Jersey) and the United Arab Emirates (Dubai). At present EUROIMMUN has 525 employees in Germany, almost 655 worldwide. The company is ISO-certified (EN ISO 9001:2000, EN ISO 13485:2003, ISO 13485/CMDCAS).
EUROIMMUN produces reagents for medical laboratory diagnostics. In the foreground are test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies. The test methods employed are predominantly indirect immunofluorescence, microplate ELISA, various blot techniques (Westernblot, EUROASSAY, EUROLINE, EUROLINE-WB) and all molecular biology techniques. The company is based on worldwide-patented state-of-the-art production methods and microanalysis techniques and is one of the world’s leading manufacturers of medical laboratory diagnostics.
The BIOCHIPs are one of EUROIMMUN’s many inventions: paper-thin sheets of glass are coated with cells or tissue sections and then cut automatically into millimetre-sized fragments which are subsequently glued onto slides using a fully automated device. This BIOCHIP technology allows extreme miniaturization and standardization of immunbiochemical analyses. With BIOCHIP Mosaics™made from 30 or more different organ sections, cell substrates or defined antigens (EUROPLUS™) only minimum incubation efforts are necessary to obtain a detailed antibody profile.
In EUROIMMUN enzyme immunoassays (ELISA) defined antigens, purified using state-of-the-art biotechnological processes, are employed as the antigen substrate. Some of these antigens are synthesized in the company’s molecular biology laboratories. EUROIMMUN ELISA are characterized by their excellent stability, simple handling and short incubation times, and they are ideal for automated use. All reagents are delivered ready-to-use and are exchangeable between different lots. EUROIMMUN offers the largest and most differentiated arsenal of enzyme immunoassays worldwide for the diagnosis of autoimmune and infectious diseases.
|
|
http://www.euroimmun.de
|
|
|
|
|
|
|
|
|
|
|
|